ATX 13.6% 10.0¢ amplia therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-29

  1. 831 Posts.
    lightbulb Created with Sketch. 206
    I think it'd have to be FOLFIRINOX.

    Point 2 is very valid and makes you think that ATX would really struggle to run a trial like that - It leads you think it'd be a takeover pre-phase 3.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.012(13.6%)
Mkt cap ! $27.42M
Open High Low Value Volume
9.4¢ 10.0¢ 9.0¢ $34.82K 369.5K

Buyers (Bids)

No. Vol. Price($)
1 5000 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 28571 1
View Market Depth
Last trade - 15.31pm 01/08/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.